BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 19669798)

  • 21. Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity.
    Liu S; Rowe PS; Vierthaler L; Zhou J; Quarles LD
    J Endocrinol; 2007 Jan; 192(1):261-7. PubMed ID: 17210763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FGF23 and syndromes of abnormal renal phosphate handling.
    Bergwitz C; Jüppner H
    Adv Exp Med Biol; 2012; 728():41-64. PubMed ID: 22396161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FGF23 and Bone and Mineral Metabolism.
    Fukumoto S
    Handb Exp Pharmacol; 2020; 262():281-308. PubMed ID: 31792685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathophysiology of hypophosphatemia.
    Ito N; Hidaka N; Kato H
    Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101851. PubMed ID: 38087658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4.
    Gattineni J; Alphonse P; Zhang Q; Mathews N; Bates CM; Baum M
    Am J Physiol Renal Physiol; 2014 Feb; 306(3):F351-8. PubMed ID: 24259513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Regulation and disorders of calcium and phosphate metabolism].
    Michigami T
    Clin Calcium; 2014 Feb; 24(2):169-75. PubMed ID: 24473349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The phosphatonins and the regulation of phosphate transport and vitamin D metabolism.
    Sommer S; Berndt T; Craig T; Kumar R
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):497-503. PubMed ID: 17224271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factor 23 as a phosphotropic hormone and beyond.
    Fukumoto S; Shimizu Y
    J Bone Miner Metab; 2011 Sep; 29(5):507-14. PubMed ID: 21822586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphate wasting and fibroblast growth factor-23.
    Nanes MS
    Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):523-31. PubMed ID: 24157604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Mutation in the Dmp1 Gene Alters Phosphate Responsiveness in Mice.
    Ichikawa S; Gerard-O'Riley RL; Acton D; McQueen AK; Strobel IE; Witcher PC; Feng JQ; Econs MJ
    Endocrinology; 2017 Mar; 158(3):470-476. PubMed ID: 28005411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble klotho and autosomal dominant polycystic kidney disease.
    Pavik I; Jaeger P; Ebner L; Poster D; Krauer F; Kistler AD; Rentsch K; Andreisek G; Wagner CA; Devuyst O; Wüthrich RP; Schmid C; Serra AL
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):248-57. PubMed ID: 22193235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model.
    Nakatani T; Ohnishi M; Razzaque MS
    FASEB J; 2009 Nov; 23(11):3702-11. PubMed ID: 19584304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D and type II sodium-dependent phosphate cotransporters.
    Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
    Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Disorders of phosphate metabolism].
    Fukumoto S
    Rinsho Byori; 2010 Mar; 58(3):225-31. PubMed ID: 20408440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.
    Shimada T; Mizutani S; Muto T; Yoneya T; Hino R; Takeda S; Takeuchi Y; Fujita T; Fukumoto S; Yamashita T
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6500-5. PubMed ID: 11344269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical aspect of recent progress in phosphate metabolism. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23)].
    Endo I
    Clin Calcium; 2009 Jun; 19(6):815-20. PubMed ID: 19483276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets.
    Razali NN; Hwu TT; Thilakavathy K
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1009-17. PubMed ID: 25894638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FGF23 directly inhibits osteoprogenitor differentiation in Dmp1-knockout mice.
    Courbon G; Kentrup D; Thomas JJ; Wang X; Tsai HH; Spindler J; Von Drasek J; Ndjonko LM; Martinez-Calle M; Lynch S; Hivert L; Wang X; Chang W; Feng JQ; David V; Martin A
    JCI Insight; 2023 Dec; 8(24):. PubMed ID: 37943605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Therapies for Hypophosphatemia-Related to FGF23 Excess.
    Athonvarangkul D; Insogna KL
    Calcif Tissue Int; 2021 Jan; 108(1):143-157. PubMed ID: 32504139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast growth factor 23 and its receptors.
    Yu X; White KE
    Ther Apher Dial; 2005 Aug; 9(4):308-12. PubMed ID: 16076372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.